title: Particulate nature of inhaled zinc oxide nanoparticles determines systemic effects and mechanisms of pulmonary inflammation in mice.
abstract: Inhalation of zinc oxide nanoparticles (ZnONP) has potential health impact. Because zinc ion may involve in the toxicity of ZnONP, we compared adverse effects of inhaled aerosolized ZnONP and zinc nitrate in mice. Aerosolized ZnONP and zinc nitrate were well-dispersed in the inhalation chamber. Inhalation of 0.86 mg/m(3) ZnONP or 1.98 mg/m(3) zinc nitrate for 5 h caused acute inflammation mainly at bronchioloalveolar junctions of lungs at 24-h post-exposure. Inhalation of ZnONP or zinc nitrate increased metallothionein expression in the epithelial cells of brochioloalveolar junction. While the effects on cytokines secretion in bronchoalveolar lavage were similar between ZnONP and zinc nitrate, only ZnONP increased lactate dehydrogenase activity. However, repeated exposure to 0.86 mg/m(3) ZnONP 5 h/day for 5 days failed to cause a similar adverse effect. Either single or repeated exposure to 0.86 mg/m(3) ZnONP increased activities of glutamate oxaloacetate transaminase, glutamate pyruvate transaminase and creatine phosphokinase in blood. In contrast, exposure to zinc nitrate had no similar systemic effects. In human bronchial epithelial cells, ZnONP-induced interleukin-8 secretion was partially prevented by co-treatment with the Toll-like receptor 4 (TLR4) inhibitor. Furthermore, ZnONP-induced pulmonary inflammation was greater in wild-type mice than in TLR4-deficent mice. It appears that ZnONP-induced acute pulmonary inflammation partially depended on TLR4. In summary, we demonstrated the dose-responsive effects for inhalation of ZnONP and zinc nitrate in mice. The threshold of cytokines induction for inhalation of ZnONP for 5 h was 0.43 mg/m(3). The particulate characters of ZnONP might contribute to the systemic adverse effects and shall be evaluated for assessing its health impact in humans.
authors.affiliation: Center for Nanomedicine Research and.
authors.forename: Jen-Kun
authors.initials: JK
authors.lastname: Chen
authors.forename: Chia-Chi
authors.initials: CC
authors.lastname: Ho
authors.forename: Han
authors.initials: H
authors.lastname: Chang
authors.forename: Jing-Fang
authors.initials: JF
authors.lastname: Lin
authors.forename: Chung Shi
authors.initials: CS
authors.lastname: Yang
authors.forename: Ming-Hsien
authors.initials: MH
authors.lastname: Tsai
authors.forename: Hui-Ti
authors.initials: HT
authors.lastname: Tsai
authors.forename: Pinpin
authors.initials: P
authors.lastname: Lin
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008168:Lung / Q000166:cytology / Q000187:drug effects* / Q000473:pathology; D053768:Metal Nanoparticles / Q000008:administration & dosage / Q000737:chemistry / Q000633:toxicity*; D051379:Mice; D008807:Mice, Inbred BALB C; D009566:Nitrates / Q000008:administration & dosage / Q000633:toxicity; D010316:Particle Size; D011014:Pneumonia / Q000139:chemically induced* / Q000378:metabolism; D017967:Zinc Compounds / Q000008:administration & dosage / Q000633:toxicity; D015034:Zinc Oxide / Q000008:administration & dosage / Q000737:chemistry / Q000633:toxicity*
chemical_list: D016207:Cytokines; D009566:Nitrates; D017967:Zinc Compounds; C042103:zinc nitrate; D015034:Zinc Oxide
keywords: Inflammation; inhalation; nanoparticles; systemic effect; zinc oxide